Accueil   Diary - News   All news Fab’entech is going to install its offices and its proprietary industrial unit on the site of the pharmaceutical company Delpharm located in the Biodistrict of Lyon (France)

Fab’entech is going to install its offices and its proprietary industrial unit on the site of the pharmaceutical company Delpharm located in the Biodistrict of Lyon (France)

Lyon, France – 04th January 2018 – Fab’entech, a privately-owned biopharmaceutical company specialized in the development and manufacturing of emergency immunotherapies, is pleased to announce that it has signed a letter of intent with the French pharmaceutical company Delpharm, in order to build its proprietary industrial unit and to install its offices and laboratories on Delpharm’s manufacturing site in Lyon.

 


The two companies are currently finalizing the terms of the related agreement, which will be be signed in the next few weeks and which will provide Fab’entech with an access to some areas of Delpharm’s Lyon site. The other terms of the agreement are not disclosed.

 


With this very strategic project, strongly supported by its Board and BPI France, Fab’entech will regroup all its activities in a unique site located at the heart of the Lyon Biodistrict.

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree